Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Harvard Business School
Boehringer Ingelheim
Colorcon
Johnson and Johnson

Last Updated: January 28, 2023

CLINICAL TRIALS PROFILE FOR INVANZ


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Invanz

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00379951 ↗ A Study to Assess the Safety, Tolerability and Efficacy of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-048) Completed Merck Sharp & Dohme Corp. Phase 3 2005-06-01 The purpose of this study is to evaluate the safety, tolerability and efficacy of ertapenem sodium as initial therapy for the treatment of complicated urinary tract infections, including pyelonephritis in indian adults.
NCT00397956 ↗ To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053) Completed Merck Sharp & Dohme Corp. Phase 3 2004-09-01 To collect clinical response data with the use of ertapenem in community acquired sepsis.
NCT00398099 ↗ To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052) Completed Merck Sharp & Dohme Corp. Phase 3 2005-07-01 To collect clinical response data with the use of ertapenem in approved indications.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Invanz

Condition Name

Condition Name for Invanz
Intervention Trials
Urinary Tract Infection 3
Antibiotic Resistant Infection 2
Complicated Infection 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Invanz
Intervention Trials
Infections 8
Infection 8
Communicable Diseases 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Invanz

Trials by Country

Trials by Country for Invanz
Location Trials
United States 44
Latvia 5
India 5
Romania 4
Bulgaria 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Invanz
Location Trials
California 5
Michigan 5
Massachusetts 3
Montana 3
Missouri 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Invanz

Clinical Trial Phase

Clinical Trial Phase for Invanz
Clinical Trial Phase Trials
Phase 4 5
Phase 3 9
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Invanz
Clinical Trial Phase Trials
Completed 15
Unknown status 2
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Invanz

Sponsor Name

Sponsor Name for Invanz
Sponsor Trials
Merck Sharp & Dohme Corp. 7
Tetraphase Pharmaceuticals, Inc. 3
Iterum Therapeutics, International Limited 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Invanz
Sponsor Trials
Other 21
Industry 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Mallinckrodt
Moodys
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.